Cohance Lifesciences Ltd

NSE: COHANCE BSE: 543064

₹311.95

(3.48%)

Mon, 06 Apr 2026, 10:49 am

MTF 5xInvest in Cohance Lifesciences Ltd with 5x Leverage Buy with MTF

Market Cap115.5B

PE Ratio54.25

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Company History

2018

The Company was incorporated as a public limited company under the Companies Act, 2013.

2020

Suven Pharmaceuticals Ltd. issued Bonus Shares in the Ratio of 1:1.

2021

CSIR-IICT and Suven Pharmaceuticals Ltd. collaborated for the process technology transfer and manufacture of anti COVID drugs Molnupiravir and 2-DG.

2022

Advent acquired a significant stake in Suven Pharmaceuticals from the Jasti family.
Suven Pharmaceuticals approved the acquisition of Casper Pharma.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800